1699720-85-8 Usage
Uses
Used in Pharmaceutical Industry:
(3S,6S,12aR)-6-isobutyl-9-methoxy-3-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione is used as a potential pharmaceutical candidate for [specific application reason] due to its unique structure and potential pharmacological properties.
Used in Research and Development:
(3S,6S,12aR)-6-isobutyl-9-methoxy-3-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione is used as a research compound for studying its chemical properties, biological activities, and potential applications in various fields.
Note: The specific application reason in the pharmaceutical industry and other industries is not provided in the materials. Further research and information are needed to determine the exact uses and applications of (3S,6S,12aR)-6-isobutyl-9-methoxy-3-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione.
Check Digit Verification of cas no
The CAS Registry Mumber 1699720-85-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,9,9,7,2 and 0 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1699720-85:
(9*1)+(8*6)+(7*9)+(6*9)+(5*7)+(4*2)+(3*0)+(2*8)+(1*5)=238
238 % 10 = 8
So 1699720-85-8 is a valid CAS Registry Number.
1699720-85-8Relevant academic research and scientific papers
Synthesis of a new inhibitor of breast cancer resistance protein with significantly improved pharmacokinetic profiles
Li, Yuexian,Woo, Jiyeon,Chmielecki, Jessica,Xia, Cindy Q.,Liao, Mingxiang,Chuang, Bei-Ching,Yang, Johnny J.,Guan, Miao Y.,Plesescu, Mihaela,Prakash, Shimoga R.
supporting information, p. 551 - 555 (2016/01/09)
The design, synthesis, in vitro inhibitory potency, and pharmacokinetic (PK) profiles of Ko143 analogs are described. Compared to commonly used Ko143, the new breast cancer resistance protein (BCRP) inhibitor (compound A) showed the same potency and a sig
INHIBITOR OF BREAST CANCER RESISTANCE PROTEIN (BCRP)
-
Paragraph 00125-00128; 00137-00141, (2015/04/28)
Disclosed are compounds that inhibit breast cancer resistance protein (BCRP), of which compound (I-1), ((3S, 6S, 12aS)-6-isobutyl-9-methoxy-3-methyl-2,3,6,7, 12, 12a- hexahydropyrazino[1',2': 1,6]pyrido[3,4-b]indole-1,4-dione) or a pharmaceutically accept
